Granules India Independent Director C Parthasarathy resigns

Published On 2019-12-27 10:25 GMT   |   Update On 2019-12-27 10:25 GMT

C Parthasarathy was serving the company since May 27, 2009. However, he submitted his resignation from the Board of Governors of Granules India Ltd. on 24th December 2019. His resignation was received by the company on December 26.


Hyderabad: Hyderabad-based drugmaker, Granules India recently informed the bourses that C Parthasarathy has resigned as an independent director of the company, effective December 26 2019.


Parthasarathy was serving the company since May 27, 2009. However, he submitted his resignation from the Board of Governors of Granules India Ltd. on 24th December 2019. His resignation was received by the company on December 26.


Read Also: Granules India gets USFDA nod for allergy treatment drug Loratadine


In his resignation letter, Parthasarathy said, “Further to the discussions that the undersigned had with your chairman and managing director C Krishna Prasad, I hereby tender my resignation from the board of governors of Granules India Ltd. I would be grateful if necessary formalities pertaining to my resignation are completed at the earliest and the details are intimated to me.”


"I would like to thank the Chairman and Managing Director and Members of the Board for their warmth, support, and the mutual cooperation during my tenure on the Board," the letter added.


Read Also: Granules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptoms

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News